Aortic Valve Incompetence
8
0
0
7
Key Insights
Highlights
Success Rate
88% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 47/100
12.5%
1 terminated out of 8 trials
87.5%
+1.0% vs benchmark
0%
0 trials in Phase 3/4
57%
4 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (8)
Aortic or Mitral Valve Replacement With the Braile Biomédica® Bovine Pericardium Valvular Bioprosthesis
Trifecta™ Long Term Follow-Up (LTFU) Study
Surgical Treatment of Aortic Stenosis With a Next Generation, Rapid Deployment Surgical Aortic Valve
Aortic Valve Replacement With Trifecta(TM)
An Observational, Prospective Evaluation of the Trifecta™ Valve
Aortic or Mitral Valve Replacement With the Biocor and Biocor Supra
Aortic Valve Replacement With Trifecta(TM)
Perceval S Aortic Heart Valve Study- North America